Impact of COVID-19 Pandemic on Clinical and Embryological Outcomes of Assisted Reproductive Techniques

Overview

Journal J Hum Reprod Sci

Date 2022 Aug 5

PMID 35928469

Authors

Manish Banker

Parul Arora

Jwal Banker

Anand Shah

Reena Gupta

Sandeep Shah

Affiliations

Soon will be listed here.

Abstract

Background: The emergence of the COVID pandemic unfolded a series of precautions and dilemmas and the complete suspension of health services. With the gradual emergence of data showing near minimal effects of the virus on pregnancy, Assisted Reproductive Techniques (ART) services were gradually resumed following guidelines and advisories.

Aim: The purpose of this study was to detect the COVID positivity rate in women undergoing ART treatment during the COVID pandemic and compare clinical and embryological outcomes to the ART cycles performed in the pre-COVID era.

Study Setting And Design: This was a retrospective cohort study of all women undergoing controlled ovarian stimulation, followed by a fresh or frozen embryo transfer (ET) between 1st October 2019 and 31st March 2020 (control group) and between 1st April 2020 and 31st September 2020 (study group) at Nova IVF Fertility Clinic, Ahmedabad.

Material And Methods: The study group underwent ART during the first wave of COVID-19 pandemic in India and when gradual unlocking of facilities including ART was advised as per the national ART advisory by the ICMR in December 2020. The outcomes were compared with the control group (cycles in pre-covid time).

Statistical Analysis: Statistical analysis was performed in SPSS (v25.0) and included Mann-Whitney U, Fisher's exact and Pearson Chi-square as appropriate. Values of < 0.05 were considered statistically significant.

Results: A total of 367 fertilisation (IVF) stimulations were initiated. A total of 342 retrievals and 606 ETs (171 fresh and 435 frozen) were completed during the study period with a COVID positivity rate of 6.8% (25/367) amongst fresh and 3.9% (18/453) amongst frozen ETs, respectively; the PR and IR in the study group was similar to the control group (47.6 vs. 55.1 = 0.4 and 68.7 vs. 66.4; = 0.52, respectively). The maternal complication rates were similar in both groups with a COVID positivity rate of 10.2% (23/225) and 1 maternal death in the study group. The live birth rates were similar.

Conclusions: We did not find a noteworthy difference in the clinical and embryological outcomes in the IVF cycles conducted in the COVID era as compared to the pre-COVID time. Thus, with adequate precautions and safety measures, ART services conducted during the COVID pandemic have comparable birth outcomes and can be safely advocated.

Citing Articles

The Effect of COVID-19 and COVID-19 Vaccination on Assisted Human Reproduction Outcomes: A Systematic Review and Meta-Analysis.

Milostic-Srb A, Srb N, Talapko J, Mestrovic T, Ziger T, Pacaric S Diseases. 2024; 12(9).

PMID: 39329870 PMC: 11431602. DOI: 10.3390/diseases12090201.

Influence of COVID-19 infection on early pregnancy outcomes in different periods around frozen embryo transfer.

Ko Y, Chen L, Zhou C, Xi J, Xiao Y, Chen X BMC Pregnancy Childbirth. 2024; 24(1):440.

PMID: 38914960 PMC: 11194866. DOI: 10.1186/s12884-024-06646-1.

Outcomes of female reproductive performance with assisted reproductive techniques after recent mild to moderate COVID-19 infections: An observational study.

Moini A, Najafpour N, Kashani L, Farid-Mojtahedi M, Maleki-Hajiagha A, Tehranian A Clin Exp Reprod Med. 2024; 51(3):268-275.

PMID: 38525519 PMC: 11372315. DOI: 10.5653/cerm.2023.06352.

SARS-CoV-2 infection and female reproductive health: A narrative review.

Maher M, Owens L Best Pract Res Clin Endocrinol Metab. 2023; 37(4):101760.

PMID: 36990807 PMC: 9977073. DOI: 10.1016/j.beem.2023.101760.

Assisted reproductive technology in Japan: A summary report for 2020 by the ethics Committee of the Japan Society of obstetrics and gynecology.

Katagiri Y, Jwa S, Kuwahara A, Iwasa T, Ono M, Kato K Reprod Med Biol. 2023; 22(1):e12494.

PMID: 36618448 PMC: 9811980. DOI: 10.1002/rmb2.12494.

References

Banker M, Mehta V, Sorathiya D, Dave M, Shah S . Pregnancy outcomes and maternal and perinatal complications of pregnancies following fertilization/intracytoplasmic sperm injection using own oocytes, donor oocytes, and vitrified embryos: A prospective follow-up study. J Hum Reprod Sci. 2017; 9(4):241-249. PMC: 5296828. DOI: 10.4103/0974-1208.197666. View

Joseph N, Rasmussen S, Jamieson D . The effects of COVID-19 on pregnancy and implications for reproductive medicine. Fertil Steril. 2021; 115(4):824-830. PMC: 7775651. DOI: 10.1016/j.fertnstert.2020.12.032. View

Pan F, Xiao X, Guo J, Song Y, Li H, Patel D . No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019. Fertil Steril. 2020; 113(6):1135-1139. PMC: 7164916. DOI: 10.1016/j.fertnstert.2020.04.024. View

Vaiarelli A, Bulletti C, Cimadomo D, Borini A, Alviggi C, Ajossa S . COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine. Reprod Biomed Online. 2020; 40(6):755-759. PMC: 7141636. DOI: 10.1016/j.rbmo.2020.04.003. View

Gianaroli L, Ata B, Lundin K, Rautakallio-Hokkanen S, Tapanainen J, Vermeulen N . The calm after the storm: re-starting ART treatments safely in the wake of the COVID-19 pandemic. Hum Reprod. 2020; 36(2):275-282. PMC: 7665491. DOI: 10.1093/humrep/deaa285. View

Jirge P, Patwardhan S, Jirge S, Bhomkar D, Chougule S, Salpekar A . Resuming Assisted Reproduction Services during COVID-19 Pandemic: An Initial Indian Experience. J Hum Reprod Sci. 2021; 13(4):323-332. PMC: 7879848. DOI: 10.4103/jhrs.JHRS_211_20. View

Somigliana E, Esposito G, Vigano P, Franchi M, Corrao G, Parazzini F . Effects of the early phase of the COVID-19 pandemic on natural and ART-mediated birth rates in Lombardy Region, Northern Italy. Reprod Biomed Online. 2021; 43(4):765-767. PMC: 8496890. DOI: 10.1016/j.rbmo.2021.07.017. View

Ata B, Gianaroli L, Lundin K, Mcheik S, Mocanu E, Rautakallio-Hokkanen S . Outcomes of SARS-CoV-2 infected pregancies after medically assisted reproduction. Hum Reprod. 2021; 36(11):2883-2890. PMC: 8523208. DOI: 10.1093/humrep/deab218. View

Koya S, Ebrahim S, Bhat L, Vijayan B, Khan S, Jose S . COVID-19 and Comorbidities: Audit of 2,000 COVID-19 Deaths in India. J Epidemiol Glob Health. 2021; 11(2):230-232. PMC: 8242123. DOI: 10.2991/jegh.k.210303.001. View

10.

Villar J, Ariff S, Gunier R, Thiruvengadam R, Rauch S, Kholin A . Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr. 2021; 175(8):817-826. PMC: 8063132. DOI: 10.1001/jamapediatrics.2021.1050. View

11.

Muralidar S, Ambi S, Sekaran S, Krishnan U . The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2. Biochimie. 2020; 179:85-100. PMC: 7505773. DOI: 10.1016/j.biochi.2020.09.018. View

12.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

13.

Schwartz D, Graham A . Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections. Viruses. 2020; 12(2). PMC: 7077337. DOI: 10.3390/v12020194. View

14.

Setti P, Cirillo F, Immediata V, Morenghi E, Canevisio V, Ronchetti C . First trimester pregnancy outcomes in a large IVF center from the Lombardy County (Italy) during the peak COVID-19 pandemic. Sci Rep. 2021; 11(1):16529. PMC: 8368203. DOI: 10.1038/s41598-021-96134-9. View

15.

Barragan M, Guillen J, Martin-Palomino N, Rodriguez A, Vassena R . Undetectable viral RNA in oocytes from SARS-CoV-2 positive women. Hum Reprod. 2020; 36(2):390-394. PMC: 7543480. DOI: 10.1093/humrep/deaa284. View

16.

Demirel C, Tulek F, Celik H, Donmez E, Tuysuz G, Gokcan B . Failure to Detect Viral RNA in Follicular Fluid Aspirates from a SARS-CoV-2-Positive Woman. Reprod Sci. 2021; 28(8):2144-2146. PMC: 7899067. DOI: 10.1007/s43032-021-00502-9. View

17.

Engels Calvo V, Cruz Melguizo S, Abascal-Saiz A, Forcen Acebal L, Sanchez-Migallon A, Recarte P . Perinatal outcomes of pregnancies resulting from assisted reproduction technology in SARS-CoV-2-infected women: a prospective observational study. Fertil Steril. 2021; 116(3):731-740. PMC: 8041182. DOI: 10.1016/j.fertnstert.2021.04.005. View

18.

Wang M, Yang Q, Ren X, Hu J, Li Z, Long R . Investigating the impact of asymptomatic or mild SARS-CoV-2 infection on female fertility and fertilization outcomes: A retrospective cohort study. EClinicalMedicine. 2021; 38:101013. PMC: 8259363. DOI: 10.1016/j.eclinm.2021.101013. View

19.

Song C, Wang Y, Li W, Hu B, Chen G, Xia P . Absence of 2019 novel coronavirus in semen and testes of COVID-19 patients†. Biol Reprod. 2020; 103(1):4-6. PMC: 7184456. DOI: 10.1093/biolre/ioaa050. View

20.

Prasad S, Trivedi P, Malhotra N, Patil M, Swaminathan D, Shukla S . Joint IFS-ISAR-ACE Recommendations on Resuming/Opening up Assisted Reproductive Technology Services. J Hum Reprod Sci. 2020; 13(2):82-88. PMC: 7394091. DOI: 10.4103/jhrs.JHRS_109_20. View